CDC, U.S. Public Health Service advise use of daily HIV-prevention pill among at-risk populations

ATLANTA — The Centers for Disease Control and Prevention on Wednesday released guidance advising practitioners to offer an HIV prevention pill to healthy individuals who are at high-risk for an HIV infection, according to published reports. 

The guidelines, issued in conjunction with the U.S. Public Health Service, involve the use of pre-exposure prophylaxis, a strategy in which at-risk individuals take a daily dose of an antiretroviral drug to reduce their risk of HIV infection.

The guidelines replace interim guidance that emerged after studies showed PrEP to be effective in different patient populations.